On 18 September 2020, China’s State Administration for Market Regulation (SAMR) published the final version of the Anti-Monopoly Compliance Guidelines for Business Operators (Antitrust Compliance Guidelines)[1]. The guidelines provide a framework for how business operators should establish an antitrust compliance system and manage antitrust compliance risks in China. The Antitrust Guidelines are not mandatory but are indicative of the key aspects SAMR would expect to see in a good compliance programme. 

China’s National Development and Reform Commission published Draft Guidelines on the Determination of Illegal Gains and Fines in Relation to Business Operators’ Monopolistic Conduct for public consultation.

China’s National Development and Reform Commission formally launched a large scale and systematic antitrust and price inspection into China’s pharmaceutical and medical devices industries

On 15 October 2015, Mofcom and the European Commission entered into a best practices framework for cooperation in reviewing mergers. The framework marks growing cooperation between regulators handling multinational transactions. Find out what this means in practice.